Atlas Trials

A Pharmacokinetic Study of MIN-101 and Its Metabolites in Healthy Subjects to Compare MIN-101 in Poor and Extensive Metabolizers

Clinical trial NCT03072056 · COMPLETED

Trial details

NCT number
NCT03072056
Sponsor
Minerva Neurosciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2017-01-09
Primary completion
2017-07-07
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.